Ranbaxy Bids For Merck Generics Arm | Chemical & Engineering News
Volume 85 Issue 12 | p. 17 | Concentrates
Issue Date: March 19, 2007

Ranbaxy Bids For Merck Generics Arm

Department: Business

New Delhi-based Ranbaxy Laboratories confirms that it has put in a bid to acquire the generic pharmaceuticals business of Merck KGaA. Ranbaxy says it was compelled to comment on rumors of its interest in the unit in order to deny that its offer is worth as much as $6 billion. The $6 billion figure appearing in media reports is "incorrect and speculative," Ranbaxy says. Merck is selling the business to help pay for its acquisition of Serono, the Swiss biotech company. Merck's generics business reported sales of $2.3 billion in 2006.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment